Research

Stories about Princeton research relevant to a corporate and foundation audience.

  • Princeton Announces Engage 2020, New Innovation and Entrepreneurship Conference

    Wednesday, Oct 14, 2020

    The mission of Princeton University will be brought to life in a new way through Engage 2020, the inaugural innovation and entrepreneurship conference scheduled for November 4-6, 2020. Presented by the Princeton innovation and entrepreneurship team and its campus partners, Engage 2020 will offer more than 50 live, online sessions of relevance to academia, business and industry, Princeton alumni, entrepreneurs, investors, foundations and the intellectually curious.

  • Invention sparked by COVID-19 pandemic safely disinfects surfaces continuously

    Monday, Oct 12, 2020
    by Larry Bernard, Princeton Plasma Physics Laboratory

    An invention to apply plasma to frequently touched items for continuous disinfection could provide a safe and effective, non-chemical way to reduce pathogens on various surfaces such as keypads, escalator handrails and other high-touch surfaces, Princeton Plasma Physics Laboratory (PPPL) inventors say.

    The invention (patent pending) directs cold plasma from different orientations to keep surfaces disinfected without hand sanitizer, sprays, ultraviolet light or other chemical-based solutions.

  • How exactly do we spread droplets as we talk? Engineers found out.

    Monday, Oct 12, 2020
    by Adam Hadhazy, Office of Engineering Communications

    For the first time, researchers have directly visualized how speaking produces and expels droplets of saliva into the air. The smallest droplets can be inhaled by other people and are a primary way that respiratory infections like COVID-19 spread from person to person.

  • Princeton Catalysis Initiative signs agreement with Genmab to forge strong community bond

    Friday, Oct 9, 2020
    by Wendy Plump, Department of Chemistry

    Opening a new chapter in community-based collaboration, the Princeton Catalysis Initiative (PCI) has signed a partnership agreement with Genmab, an international biotech company based in Denmark with U.S. headquarters in Plainsboro. This is the sixth partnership for PCI in just over two years. 

    PCI enables new synergies and mission-inspired projects between Princeton University researchers and corporate scientists. The Genmab partnership was officially launched this month during a socially distanced tour of Genmab's state-of-the-art facilities. 

  • Through Princeton Catalysis Initiative, Genentech will fund faculty research to accelerate drug discovery

    Friday, Jul 31, 2020
    by Wendy Plump, Department of Chemistry

    A new relationship between the Princeton Catalysis Initiative (PCI) and Genentech, a biotechnology company based in South San Francisco, is enabling several Princeton faculty members to pursue mission-driven collaborations in fundamental research.

    Genentech will fund five new projects, raising PCI’s total funded commitments to over $65M in just over two years.

Pages

Subscribe to Research